Menu
February 22, 2021

Experimental COVID Vaccines: Mounting Deaths Reported in Media and Social Media … Part 6 of 7

Overview

Deaths and adverse events following COVID vaccines continue to mount as over 200 million doses administered worldwide. The “rare” life-threatening vaccine-related complication of immune thrombocytopenia purpura (ITP) turns out to be not-so-rare. Are health authorities and public health agencies ignoring warnings of concerned medical specialists that these vaccines could cause infertility? We revisit COVID vaccine-related adverse pregnancy outcomes of premature labor, miscarriage, hydrops fetalis, and fetal death here and abroad. Vaccine manufacturers have no liability for injuries or death from their products. Is exposing our children to the real risks of experimental COVID vaccines really in their best interest, especially when they have a statistical zero risk to the virus? Updated death reports and more, in today’s article.


By Dawn Amittai

Worldwide Administration of Experimental COVID Vaccines Hits Over 200 Million Doses in 88 Countries 

As COVID vaccination programs continue rolling out worldwide, the latest numbers show 202 million doses in a total of 88 countries have been administered. In the US alone, nearly 43 million Americans have had their first shot. For the most recent figures see Table 1:

table 1 COVID Vaccines

The Experimental COVID Vaccines: The Trail of Death, Serious Injuries and Disabilities Continues to Mount…

CDC’s phased COVID vaccination program began mid-December with Phase 1a — frontline medical workers and the elderly in long-term care facilities — and continues to leave a trail of death, disabilities, and serious injuries in its wake. Last week we shared the tragic stories of 2 physicians in their 30’s, and a 28-year-old medical worker named Sara, whose lives were tragically cut short following COVID vaccines. As Phase 1b — vaccinatingFarwell Area Schools essential frontline workers — began its rollout across the nation, we heard about school closures due to teachers, school staff, substitutes, aides, and bus drivers becoming ill after receiving vaccines. This week it seems school districts are adjusting their schedules proactively, to accommodate employees’ potential adverse effects following their COVID vaccination programs.

For example, Farwell Area Schools in Clare County Michigan closed for the day to allow staff to rest and recover after receiving the second dose of the vaccine. This week we are also hearing reports of other essential frontline workers such as firefighters, police, MTA workers, and more. The president of the Des Moines Firefighters’ Union was in the news, expressing his dismay that firefighters were having to take regular sick leave — instead of paid leave from the city — in order to take time off to recover from adverse effects from COVID shots. Des Moines Firefighters

Of 2,053 firefighters polled by the Uniformed Firefighters Association (UFA), 55% said they would refuse Pfizer’s COVID vaccine when the department makes it available. NBC 5 Investigates questioned various police and fire departments about how they will handle employees refusing COVID vaccines, and all expressed they will “…leave it up to each individual to decide what is right for them” — no vaccine mandates are planned. In Richardson Texas, 50% of police officers and 68% of emergency medical services (EMS) staff have opted out so far. A survey of MTA workers, also considered Phase 1b frontline essential workers by CDC’s program, revealed only 30% were definitely willing to be vaccinated. brandon goldner

VAERS Latest Data on Deaths Following Experimental COVID Vaccines 

As of February 12th, CDC’s Vaccine Adverse Event Reporting System (VAERS) lists 929 deaths in their system — 717 in the US, 130 “foreign” and 82 “unknown” — since the experimental vaccine rollout began mid-December. An additional 611 deaths have been published by the media through February 20th, 2021. For the most recent numbers of deaths following COVID vaccines itemized by country see Table 2:

table 2 COVID Vaccine Deaths

The distribution of deaths in the US listed by state is displayed in Table 3. California continues to lead in death rates with 71 deaths reported to date; Florida is next with 55, followed by Kentucky with 43. The CDC also publishes an up-to-date tally of the number of vaccines administered in each state here. 

table 3 COVID Vaccine Deaths by VAERS

During this same period — through February 12th — a total of 15,923 adverse events were reported to and entered in VAERS, including 3,126 considered serious (see VAERS data reports). As always, keep in mind these figures represent fewer than 1% of all the actual vaccine adverse events and deaths. More accurate numbers could be calculated at 1,592,300 adverse events and 312,600 serious adverse events, and 92,900 deaths to date.

15, 923 Adverse Events Entered in VAERS by February 12, 2021

15923 Adverse Events VAERS

3,126 Serious Adverse Events Entered in VAERS by February 12, 2021

3126 adverse events VAERS

929 Fatal Events Entered in VAERS by February 12, 2021

929 Fatal Events VAERS

Experimental COVID Vaccines: Generating Hospitalizations, Emergency Room Visits, Office Visits and Permanent Disabilities

This week we continued to explore the number of adverse events entered in VAERS by February 12th which required hospitalization, visit(s) to the emergency room, visit(s) to a doctor’s office, and those reported cases resulting in permanent disability — please see Table 4.  As always, keep in mind these numbers represent fewer than 1% of all the actual events…

table 4 summary of hospitalizations

The latest CDC statistics indicate 31,270,062 Pfizer-BioNTech vaccines and 29,909,492 Moderna vaccines have been administered in the US through February 20th. 

The Pfizer vaccine received its Emergency Use Authorization (EUA) by the FDA one week ahead of Moderna’s, explaining why Pfizer continues its lead in administering more vaccines. AstraZeneca’s experimental vaccine was authorized for emergency use in UK end of December, and their rollout began first week of January; India’s brand of the AstraZeneca vaccine, Covishield, began administration mid-January in India. Currently, Pfizer’s shot continues its lead in the numbers of deaths following administration, as reported by VAERS as well as the media (see Table 5).

Using data provided by Bloomberg’s COVID-19 Vaccine Tracker, we obtained the total number of vaccine doses administered to Americans by February 12th — the most recent date VAERS uploaded reports to their system — and calculated the estimated incidence of adverse events and deaths reported by VAERS per the number of vaccines administered (see Table 6). To date: 1 out of every 31 persons taking one of these experimental COVID vaccines experiences an adverse event (3.23%); of these, 1 out of every 160 suffers a serious adverse event (0.63%), and 1 out of every 538 results in death (0.19%).

table 6 estimated incidence of events

Serious Side Effects Following COVID Vaccines Part III: Focus on the “Rare” Complication of Thrombocytopenia

We have been looking at different categories of life-threatening, permanently disabling, serious, and fatal adverse events which are being reported by VAERS and in the media worldwide. To date, we have covered various cardiac, neurological, and cerebrovascular-related cases. Today, we focus on a condition which has been popping up in the news recently, which has been considered by medical authorities to be a rare disorder — immune (aka idiopathic) thrombocytopenia purpura/ITP

Luz Legaspi Side EffectsOn January 19thone day after receiving her first dose of Moderna’s COVID-19 vaccine, 72-year-old Luz Legaspi awakened with bruises on her arms and legs and blisters inside her mouth, which began to bleed. The same day, she was hospitalized in New York City and diagnosed with severe immune thrombocytopenia. ITP is an autoimmune disorder, where the immune system attacks the body’s platelets, cells which are responsible for blood clotting. This leads to a decrease in their number, triggering bleeding which can range from mild bruising to life-threatening intracranial hemorrhage.

You may recall in one of our previous articles in this series we reported that Dr. Gregory Michael, a 56-year-old Miami obstetrician died from ITP 2 weeks after receiving Pfizer’s COVID-19 experimental vaccine. Michael’s wife, Heidi Neckelmann, said he sought emergency care 3 days after the shot, because he had dots on his skin that suggested internal bleeding. He was hospitalized, and his platelet count was found to be zero. She said a team of doctors tried to raise his platelet count “to no avail”; he remained conscious up until he suffered a hemorrhagic stroke, “that took his life in a matter of minutes.” 

Gregory Michael Obstetrician

As is often the case with deaths following these investigational COVID shots, vaccine experts and hematologists emphasized that this case is extremely rare, adding that the “coincidental timing of ITP and vaccination doesn’t demonstrate causality.” The one refreshing exception is Dr. Jerry L. Spivak, an expert on blood disorders at Johns Hopkins University, who, based on the description given to him by Dr. Michael’s wife, made the assessment, “I think it is a medical certainty that the vaccine was related.” This determination of Dr. Spivak’s is confirmed by a study published in NIH’s National Library of Medicine which clearly states, “Vaccines may induce ITP by several mechanisms,” and concluded, “… the occurrence of adverse events and autoimmune phenomena has been described following vaccination, and ITP may represent one of these.”

In response to Dr. Michael’s death, a spokesman from Pfizer, the vaccine manufacturer said, “‘We don’t believe at this time that there is any direct connection to the vaccine.” Chalk another one up to “death by coincidence.” Based upon the facts of this case, the assessment of a medical expert on blood disorders, as well as NIH’s published medical literature, does his death following COVID vaccination sound “coincidental”? As Robert F. Kennedy Jr. recently concluded, “Coincidence is turning out to be quite lethal to COVID vaccine recipients.” Indeed. 

It is especially “coincidental” that the FDA lists thrombocytopenia as one of the possible adverse event outcomes of COVID-19 vaccines being monitored by the Food and Drug Administration (FDA). Please note that it is included on their COVID-19 Vaccines “DRAFT Working list of possible adverse events outcomes” from their October 22, 2020 meeting (see list below):

FDA Safety COVID-19

In other words, thrombocytopenia is known to be a potential adverse outcome from these experimental vaccines. It is not a surprise. And it turns out, neither is it a rare occurrence these days. According to a New York Times article on February 10th,  36 cases of ITP following COVID vaccination had been reported to VAERS by the end of January — within 6 weeks of the COVID vaccine rollout program. Oddly, a search of VAERS for all reports of ITP uploaded by February 12th reveals only 18 of these reported to date — not 36. As is frequently the case with VAERS, it is likely due to a backlog of cases which have been reported to them, but have not yet been uploaded to their system. See VAERS data search results:

 A few examples of the cases of thrombocytopenia/ITP detailed in VAERS are: 

  • 23-year-old from Wisconsin with no prior medical history: “Patient received Pfizer COVID 19 vaccine last Thursday 12/17. Admitted today (12/21) with bleeding and low platelet count – working up for ITP, TTP. Given recency of vaccination and no known contributory allergy or medical history, physician thought potentially associated with vaccination.”
  • 25-year-old female from Washington with no significant medical history: “Severe thrombocytopenia (plts 3k/uL), oral mucosal bleeding, bruising.”
  • 43-year-old female from Massachusetts without significant medical history: “Severe thrombocytopenia (platelet count 2,000) 8 days following Moderna COVID vaccine. Clinically suspicious for ITP.”

Much like VAERS, European EudraVigilance is a vaccine adverse event reporting system for the European Economic Area (EEA), which includes all countries in the European Union (EU) as well as Iceland, Liechtenstein, and Norway. We ran a search for this “rare” disorder to explore its occurrence following both Pfizer’s and Moderna’s experimental COVID vaccines administered in European countries, and found a combined total of 3,940 reported cases (see EudraVigilance data)! Sobering indeed…

Thrombocytopenia/ITP-Related Adverse Events by February 13th, Pfizer’s COVID Vaccine: 3,937 cases 

thrombocytopenia 3937

Thrombocytopenia/ITP-Related Adverse Events by February 13th for Moderna’s COVID Vaccine: 3 cases 

Thrombocytopenia/ITP

In UK — England, Scotland, Wales and Northern Ireland — the Medicines and Healthcare products Regulatory Agency (MHRA) is the executive agency of the Department of Health and Social Care that “…acts to protect and promote public health and patient safety, by ensuring that medicines and medical devices meet appropriate standards of safety, quality and efficacy.” The MHRA operates the Yellow Card Scheme, which is responsible for collecting and monitoring information on safety concerns or incidents involving vaccines, medicines, and medical devices. 

Next, we ran a search of the Yellow Card data on reported cases of ITP following both Pfizer’s and Oxford’s AstraZeneca experimental COVID vaccines administered in UK through February 11th. We found a total of 17 reported cases during this time (see Yellow Card data):

Thrombocytopenia/ITP-Related Adverse Events Reported to UK’s Yellow Card System by February 11th for Pfzer’s COVID Vaccine: 11 cases 

pfizer analysis COVID-19

Thrombocytopenia/ITP-Related Adverse Events Reported to UK’s Yellow Card System by February 11th for AstraZeneca’s COVID Vaccine: 6 cases 

astrazeneca Analysis COVID-19

For a “rare” disorder, thrombocytopenia/ITP is proving to be not-so-rare in the wake of these COVID vaccines

Revisiting the Use of Experimental COVID Vaccines in Pregnancy

A few weeks ago in our article 3 of 3, we discussed the topic of the WHO, CDC and the Advisory Committee on Immunization Practices (ACIP) suddenly reversing their position guidelines on the use of experimental emergency-authorized COVID vaccines during pregnancy. The WHO issued their statement “… based on what we know about this kind of vaccine, we don’t have any specific reason to believe there will be specific risks that would outweigh the benefits of vaccination for pregnant women.” A week later, this was echoed by Dr. Fauci who declared, “…there have been “no red flags” from 10,000 pregnant women who have had the COVID-19 vaccine in the US.” No real explanation was offered for this sudden and surprising reversal of position, particularly when we consider the fact neither Pfizer’s nor Moderna’s experimental COVID vaccines have ever been tested on pregnant women. 

Now, the American College of Obstetricians and Gynecologists (ACOG) has updated their recommendations: “… COVID-19 vaccines should not be withheld from pregnant individuals who meet criteria for vaccination based on ACIP-recommended priority groups.” Dr. Richard Beigi from ACOG told CNN, “There’s really no theoretical reason to believe it’s going to cause harm to either the mother or her unborn child and we’re very confident it’s going to provide considerable benefits to both the mother and the baby.” And another physician speaking on an ACOG platform reassures us, “So rest assured, any vaccine that you are offered has gone through a great amount of testing and oversight. The COVID-19 vaccines are no exception.”  

Really? What data are these new recommendations based upon? Where can we find the new data supporting such critical decisions and guidelines? To the CDC’s credit, their website itself openly acknowledges, “… the actual risks of mRNA vaccines to the pregnant person and her fetus are unknown because these vaccines have not been studied in pregnant women.” So, what changed to make our health authorities throw caution to the wind? How did they all suddenly arrive at this same conclusion at the same time, even in the face of mounting hard evidence of adverse pregnancy outcomes — premature labor, miscarriages, hydrops fetalis, and fetal deaths — now appearing weekly in VAERS, in UK’s Yellow Card data, and Europe’s EudraVigilance System?  Why don’t we have a look at the most recent US, UK, and European data on pregnancy-related COVID-19 vaccine adverse event reports for ourselves?

Pregnancy-Related Adverse Events Reported to VAERS by February 12th for both Pfizer’s and Moderna’s COVID-19 Vaccines: 31 cases

found31

As an aside, Public Health UK’s guidelines for use of COVID vaccines in pregnancy issued by the Joint Committee on Vaccination and Immunisation (JCVI) recommends vaccination during pregnancy should be avoided except for those who are deemed high risk. For those considered high risk, the recommendation is a discussion with a nurse or doctor. Perhaps the slightly fewer reported pregnancy-related adverse events in UK — only a combined total of 10 cases reported as of February 11th — reflect their somewhat more cautionary approach… or it is possible that their reporting system, much like our VAERS, is less than adequate in obtaining and keeping up with the data? (See Yellow Card Scheme data reports): 

 

Pregnancy-Related Adverse Events Reported to UK Yellow Card System by February 11th for Pfizer’s COVID Vaccine: 5 cases

pfizer Pregnancy COVID-19

Pregnancy-Related Adverse Events Reported to UK’s Yellow Card System by February 11th for AstraZeneca’s COVID Vaccine: 5 cases

astrazeneca Pregnancy COVID-19

Next, we searched the number of pregnancy-related adverse events reported to the EudraVigilance System by February 13th for both Pfizer’s and Moderna’s experimental COVID vaccines, and found a total of 23 cases (see EudraVigilance data):

Pregnancy-Related Adverse Events Reported to European EudraVigilance System by February 13th for Pfizer’s COVID Vaccine: 22 cases 

Pregnancy-Related Adverse Events Reported to European EudraVigilance System by February 13th for Moderna’s COVID Vaccine: 1 case

Are these 64 pregnancy-related adverse events reported in the US, UK, and Europe not “red flags” or “specific risks that would outweigh the benefits of vaccination for pregnant women?” Is it possible these reports are just the tip of the iceberg? We are left with the nagging question: Why are our health authorities apparently missing such easily observable, critical evidence of harm? Or is it, like so many other serious adverse events and deaths following COVID vaccination, being deemed “unrelated” or “coincidental”?

And let’s not forget the warning of Dr. Sherry Tenpenny, a triple-board certified osteopathic medical doctor and an expert on the potential adverse impact of vaccines on health, who recently tweeted, “Remember that these injections are not approved for anyone under 16, so how it is ok for babies in utero?” 

Dr. Tenpenny brings up a most critical point, that we simply have no idea what the potential effects of these warp-speed developed, Emergency Use Authorized, experimental mRNA vaccines might have on a developing fetus. What can we expect to see, when these vaccine-exposed babies are born into this world over the coming months? The fact is, we do not have data… we just have no idea. At the end of the day, this is hardly comforting. Can we simply trust these recommendations from our health authorities and agencies, and put the lives of our precious unborn loved ones in their hands without solid data? 

If that is not enough basis for profound concern, Pfizer’s COVID-19 vaccine vials themselves issue a warning: “(I)t is unknown whether COVID-19 mRNA VaccineBNT162b2 has an impact on fertility.” Former vice-president and chief scientific officer at Pfizer Global, Dr. Michael Yeadon and his colleagues warned of potential fertility-specific risks involving antibodies against “spike proteins” that could disrupt the development of the placenta in vaccinated women. Since the vaccine triggers the body to produce antibodies against the SARS-CoV-2 spike protein, and spike proteins contain syncytin-homologous proteins essential for the placenta to form, another concern arises that if a woman’s immune system starts reacting against syncytin-1 protein, this could potentially render her infertile. 

These concerns can only be properly addressed over time, and with clinical trials prospectively designed to study this. Pfizer BioNTech has just announced on February 18th they are starting a clinical trial designed to enroll 4,000 pregnant women to “… evaluate safety in infants of vaccinated pregnant women and the transfer of potentially protective antibody to them. Also, infants will be followed-up for around six months.”

Good to know — but in the meantime, CDC guidelines advise pregnant women who are part of a group —e.g., Phase 1a healthcare workers, Phase 1b frontline essential workers, etc. to receive a COVID-19 vaccine, “…may choose to be vaccinated.” Could this be just another case of our health authorities and public health agencies ignoring the warnings of our concerned medical specialists and scientists? What impact will this have on our future generations?

Testing Experimental COVID Vaccines in Children… is this in their Best Interest?

The American Academy of Pediatrics (AAP) now recommends “…everyone 16 and older who meet the criteria for a priority group get vaccinated against COVID-19 and continues to push for trials in younger children and teens.” This week in the news we are hearing announcements for clinical trials of COVID vaccines in children, from 6-months to 17-years of age.

Last week ABC News announced, “There are 100, 12 to 17-year-olds participating in the Moderna adolescent trial… In about 30 days, we’re going to start another trial…” Elizabeth Hoff, the executive director of DM Clinical went on to explain, “In addition to the trials going on, even more research is expected in the years to come. There are strains coming out of South Africa and the UK and Brazil so this virus, sadly, will be with us for a long time. These COVID vaccine trials will continue for years. So, you’ll see the same companies doing different trials to test on different things, different age groups, different vital statistics.” Really. Sounds like quite the ultimate business plan… but does this make sense for our kids?

Meanwhile, in UK, the efficacy of the experimental Oxford/AstraZeneca vaccine in children is set to be tested in a new clinical trial of 300 child-volunteers between the ages of 6 and 17, to assess whether it will produce a strong immune response. Dr. Andrew Pollard, chief investigator on the Oxford vaccine trial, said: “While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.” Interesting choice of words Dr. Pollard, “…as some children may benefit from vaccination.” As always, the real question boils down to, do the benefits outweigh the risks for the children? 

We already know from the CDC statistics that the estimated fatality rate for children from 1 year of age to 19 years of age is a trifling 0.003%; or we can look at the estimated survival rate, which is a whopping 99.997%, and see that COVID-19 illness represents a very insignificant threat to survival in children. Even Chief investigator of Oxford’s vaccine trials, Dr. Andrew Pollard, openly acknowledged this.

Next, our most recent adverse reaction calculations from February 12th (see previous Table 6) show that 1 out of every 160 persons taking an experimental COVID shot suffers a serious adverse event, and 1 out of every 538 results in death. We have certainly seen sufficient evidence of serious, permanently disabling, and fatal adverse events with these experimental vaccines, to recognize they represent a far greater threat to our children’s survival than if they contracted COVID-19 illness. 

So, what are the benefits that could weigh in on a risk-benefit assessment?  Let’s refer to our previous article 2 of 2, where Dr. Fauci and the WHO acknowledged that health officials do not know if these vaccines can prevent COVID infection or the spread of the virus to others. To his credit, Dr. Fauci also admitted that the only potential benefit could be reducing the severity of symptomatic COVID-19 infection and even confessed that they do not know how long this limited immunity might last! It is quite clear that potential benefits of these vaccines are less than stellar… and let’s never forget vaccine manufacturers have zero liability for vaccine injuries or deaths from any of these experimental COVID vaccines. 

So now, let’s return to our primary question: Do the benefits of giving experimental COVID vaccinations to our young ones outweigh the risks? Does it make sense to offer our children to this massive COVID vaccine experiment, just in case “some children may benefit from vaccination?” 

***

This article contains a growing list of deaths that occurred after the experimental COVID vaccine was administered. The death reports are culled from the media and from social media, as well as from the CDC’s Vaccine Adverse Event Reporting System (VAERS). Although the deaths are temporally related to the COVID vaccination, Children’s Health Defense – California Chapter cannot claim the COVID vaccine definitively caused the deaths. That said, the symptom patterns and timing are highly suspicious, and tend to follow patterns of adverse events widely recognized to occur after other vaccinations. The death reports serve as anecdotes that may soon establish a pattern. Children’s Health Defense – California Chapter is providing regular updates on newly reported deaths that occur after COVID vaccination. As always, Children’s Health Defense – California Chapter supports fully informed consent and no medical mandates. This is not medical advice. Please share this information with, and consult your doctor.